NCT04528563View on ClinicalTrials.gov

Ketorolac for Moderate to Severe Abdominal Pain in Children

PHASE3CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

May 5, 2021

Primary Completion Date

February 5, 2023

Study Completion Date

February 6, 2023

Conditions
Abdominal PainAppendicitisAnalgesiaChild, OnlyEmergencies
Interventions
DRUG

Ketorolac Tromethamine 10 MG/ML

Non-Steroidal-Anti-Inflammatory given intravenously.

DRUG

Morphine Sulfate 10Mg/1mL Injection

Opioid commonly used for acute abdominal pain given intravenously.

Trial Locations (1)

L9H6k6

McMaster Children's Hospital, Hamilton

All Listed Sponsors
lead

Hamilton Health Sciences Corporation

OTHER